Biocon Limited has informed the Exchange regarding a press release dated July 05, 2023, titled "Biocon Biologics Expands Footprint in Emerging Markets; Takes Over the Commercialization of Biosimilars Business from Viatris in 70+ countries".
Biocon Limited has informed the Exchange regarding a press release dated July 05, 2023, titled "Biocon Biologics Expands Footprint in Emerging Markets; Takes Over the Commercialization of Biosimilars Business from Viatris in 70+ countries".